GTR provides investors with unique opportunities in the hemp and related biotechnology and healthcare spaces; accomplishing this through deep domain knowledge, including extensive research on the hemp and cannabis genomes.
The GTR management team has been investing in the hemp space since 2016 while simultaneously undertaking research to fully characterize the cannabis and hemp
GTR's multidisciplinary team is made up of proven experts in the fields of portfolio management, law, genetics, bio-medicine, agriculture, and technology.
mAPPING THE HEMP GENOME
GTR’s knowledge of plant genetics assures clients that the firm identifies the most compelling opportunities in the hemp market especially pertaining to newly discovered properties of the plant, which are accelerating legally compliant investment opportunities.